Literature DB >> 17699713

Targeting the AKT protein kinase for cancer chemoprevention.

James A Crowell1, Vernon E Steele, Judith R Fay.   

Abstract

The AKT protein kinase transduces signals from growth factors and oncogenes to downstream targets that control crucial elements in tumor development. The AKT pathway is one of the most frequently hyperactivated signaling pathways in human cancers. Available data are reviewed herein to support targeting the AKT kinase for cancer prevention. This review will present data to show that AKT is up-regulated in preneoplastic lesions across a broad range of target tissues, briefly describe drug development efforts in this area, and present evidence that down-regulation of AKT signaling may be a viable strategy to prevent cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699713     DOI: 10.1158/1535-7163.MCT-07-0120

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  64 in total

Review 1.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

2.  Prolonged exposure to insulin suppresses mitochondrial production in primary hepatocytes.

Authors:  Hui-Yu Liu; Einav Yehuda-Shnaidman; Tao Hong; Jianmin Han; Jingbo Pi; Zhenqi Liu; Wenhong Cao
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

3.  Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.

Authors:  Ciric To; Carol S Ringelberg; Darlene B Royce; Charlotte R Williams; Renee Risingsong; Michael B Sporn; Karen T Liby
Journal:  Carcinogenesis       Date:  2015-05-04       Impact factor: 4.944

4.  Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin.

Authors:  Hui-Yu Liu; Jianmin Han; Sophia Y Cao; Tao Hong; Degen Zhuo; Jianbo Shi; Zhenqi Liu; Wenhong Cao
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

5.  Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  L Allyson Checkley; Okkyung Rho; Tricia Moore; Steve Hursting; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

6.  Prolonged exposure to insulin induces mitochondrion-derived oxidative stress through increasing mitochondrial cholesterol content in hepatocytes.

Authors:  Shuang Mei; Haihua Gu; Xuefeng Yang; Huailan Guo; Zhenqi Liu; Wenhong Cao
Journal:  Endocrinology       Date:  2012-02-28       Impact factor: 4.736

7.  Energy balance modulates colon tumor growth: Interactive roles of insulin and estrogen.

Authors:  Elizabeth A Rondini; Alison E Harvey; Juan P Steibel; Stephen D Hursting; Jenifer I Fenton
Journal:  Mol Carcinog       Date:  2010-12-28       Impact factor: 4.784

8.  SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.

Authors:  Jing He; Mingxia Zhou; Xiaoyan Li; Siwen Gu; Yun Cao; Tengfei Xing; Wei Chen; Chengyu Chu; Fei Gu; Jian Zhou; Yiting Jin; Jing Ma; Duan Ma; Qiang Zou
Journal:  Oncogene       Date:  2020-01-31       Impact factor: 9.867

9.  The expression of phospho-AKT, phospho-mTOR, and PTEN in extrahepatic cholangiocarcinoma.

Authors:  Joon-Yong Chung; Seung-Mo Hong; Byeong Yeob Choi; Hyungjun Cho; Eunsil Yu; Stephen M Hewitt
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

10.  A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate.

Authors:  M Falasca; D Chiozzotto; H Y Godage; M Mazzoletti; A M Riley; S Previdi; B V L Potter; M Broggini; T Maffucci
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.